Download PDF
Thromb Haemost 2008; 100(04): 611-613
DOI: 10.1160/TH08-06-0388
Clinical Focus
Schattauer GmbH

Cardiovascular risk factors in patients at high risk of atherothrombosis: What can be learned from registries?

Shinya Goto
1   Department of Medicine (Cardiology) and the Metabolic Disease Center of Tokai University Graduate School of Medicine, and the Department of Metabolic Systems Medicine, Institute of Medical Science, Tokai University, Kanagawa, Japan
› Author Affiliations
Further Information

Publication History

Received 19 June 2008

Accepted after minor revision 19 August 2008

Publication Date:
22 November 2017 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Wilson PW. et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
    CrossrefPubMedGoogle Scholar
  • 2 Arcelus JI. et al. Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry. Thromb Haemost 2008; 99: 546-551.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Ruiz-Gimenez N. et al. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008; 100: 26-31.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Blanco-Molina A. et al. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry. Thromb Haemost 2007; 97: 186-190.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Falga C. et al. Clinical outcome of patients with venous thromboembolism and renal insufficiency. Findings from the RIETE registry. Thromb Haemost 2007; 98: 771-776.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Cohen AT. et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756-764.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Ivaskevicius V. et al. International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost 2007; 97: 914-921.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Fox KA. et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). Br Med J 2006; 333: 1091.
    CrossrefPubMedGoogle Scholar
  • 9 Bradshaw PJ. et al. Validity of the GRACE (Global Registry of Acute Coronary Events) acute coronary syndrome prediction model for six month post-discharge death in an independent data set. Heart 2006; 92: 905-909.
    CrossrefPubMedGoogle Scholar
  • 10 Parikh NI. et al. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med 2008; 148: 102-110.
    CrossrefPubMedGoogle Scholar
  • 11 Touboul PJ. et al. Correlation between the Framingham risk score and intima media thickness: the Paroi Arterielle et Risque Cardio-vasculaire (PARC) study. Atherosclerosis 2007; 192: 363-369.
    CrossrefPubMedGoogle Scholar
  • 12 Wang TJ. et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. J Am Med Assoc 2003; 290: 1049-1056.
    CrossrefPubMedGoogle Scholar
  • 13 Gordon T. et al. Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. Lancet 1974; 02: 1345-1348.
    PubMedGoogle Scholar
  • 14 Freund KM. et al. The health risks of smoking. The Framingham Study: 34 years of follow-up. Ann Epidemiol 1993; 03: 417-424.
    CrossrefPubMedGoogle Scholar
  • 15 Kannel WB. et al. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med 1979; 90: 85-91.
    CrossrefPubMedGoogle Scholar
  • 16 Wilson PW. et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867-1872.
    CrossrefPubMedGoogle Scholar
  • 17 Rosito GA. et al. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb Haemost 2004; 91: 683-689.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Teo KK. et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006; 368: 647-658.
    CrossrefPubMedGoogle Scholar
  • 19 Rosengren A. et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 953-962.
    CrossrefPubMedGoogle Scholar
  • 20 Verschuren WM. et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. J Am Med Assoc 1995; 274: 131-136.
    CrossrefPubMedGoogle Scholar
  • 21 Tunstall-Pedoe H. et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547-1557.
    CrossrefPubMedGoogle Scholar
  • 22 Kubo M. et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 2003; 34: 2349-2354.
    CrossrefPubMedGoogle Scholar
  • 23 Katsuki S. et al. Epidemiological Studies on Cer-ebrovascular Diseases in Hisayama, Kyushu Island, Japan. I. With Particular Reference to Cardiovascular Status. Jpn Heart J 1964; 127: 12-36.
    PubMedGoogle Scholar
  • 24 Kiyohara Y. et al. Ten-year prognosis of stroke and risk factors for death in a Japanese community: the Hisayama study. Stroke 2003; 34: 2343-2347.
    CrossrefPubMedGoogle Scholar
  • 25 Ueda K. et al. Intracerebral hemorrhage in a Japanese community, Hisayama: incidence, changing pattern during long-term follow-up, and related factors. Stroke 1988; 19: 48-52.
    CrossrefPubMedGoogle Scholar
  • 26 Fujishima M. et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes 1996; 45 (Suppl. 03) S14-6.
    PubMedGoogle Scholar
  • 27 Ohmori S. et al. Hyperinsulinaemia and blood pressure in a general Japanese population: the Hisayama Study. J Hypertens 1994; 12: 1191-1197.
    PubMedGoogle Scholar
  • 28 Saito T. et al. Relationship between obesity, glucose tolerance, and periodontal disease in Japanese women: the Hisayama study. J Periodontal Res 2005; 40: 346-353.
    CrossrefPubMedGoogle Scholar
  • 29 Ueda K. et al. Prevalence and long-term prognosis of mild hypertensives and hypertensives in a Japanese community, Hisayama. J Hypertens 1988; 06: 981-989.
    CrossrefPubMedGoogle Scholar
  • 30 Fujii I. et al. Natural history of borderline hypertension in the Hisayama community, Japan--I. The relative prognostic importance of transient variability in blood pressure. J Chronic Dis 1984; 37: 895-902.
    CrossrefPubMedGoogle Scholar
  • 31 Final report on the aspirin component of the ongoing Physicians’ Health Study. Steering Committee of the Physicians’ Health Study Research Group. N Engl J Med. 1989 321. 129-135.
    PubMedGoogle Scholar
  • 32 Patrono C. et al. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005; 353: 2373-2383.
    CrossrefPubMedGoogle Scholar
  • 33 Worth RM. et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: mortality. Am J Epidemiol 1975; 102: 481-490.
    CrossrefPubMedGoogle Scholar
  • 34 Ro A. et al. The factor V Leiden mutation and the prothrombin G20210A mutation was not found in Japanese patients with pulmonary thromboembolism. Thromb Haemost 1999; 82: 1769.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Ozawa T. et al. Absence of factor V Leiden in the Japanese. Thromb Res 1996; 81: 595-596.
    CrossrefPubMedGoogle Scholar
  • 36 Bhatt DL. et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. J Am Med Assoc 2006; 295: 180-189.
    CrossrefPubMedGoogle Scholar
  • 37 Yamazaki T. et al. Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan. Circ J 2007; 71: 995-1003.
    CrossrefPubMedGoogle Scholar
  • 38 Ohman EM. et al. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J. 2006 151. 786 e1–10.
    PubMedGoogle Scholar
  • 39 Steg PG. et al. One-year cardiovascular event rates in outpatients with atherothrombosis. J Am Med Assoc 2007; 297: 1197-1206.
    CrossrefPubMedGoogle Scholar